Skip to content
Screener

Natera, Inc. NTRA Gross margin

Discontinued — last reported Q3 '19

Gross margin at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
70%0.0pp
Labcorp Holdings logo
Labcorp HoldingsLH
28.9%+0.7pp
Quest Diagnostics logo
Quest DiagnosticsDGX
33.1%+0.1pp
NeoGenomics logo
NeoGenomicsNEO
43.9%0.0pp
Illumina logo
IlluminaILMN
66.4%-0.2pp
Veracyte logo
VeracyteVCYT
70.9%+2.9pp

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Cash & equivalents$1.1B+11.7%
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$38.35B+106%
Enterprise value$37.5B+110%
P/S15.3×+5.8×

Profitability

See full
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio3×-0.9×

Where this comes from

Calculated from Natera, Inc.’s reported figures.

gross profit/total revenue=42.9%

Based on trailing twelve months.

The source filing: Natera, Inc.’s 10-Q, filed November 8, 2019. Open the filing →

Filed
Nov 8, 2019
Fiscal quarter
Q3 FY2019
Calendar quarter
Q3 2019
Accession
0001558370-19-010489

FAQ

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.